Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes
Authors
Keywords
-
Journal
Current Cardiology Reports
Volume 14, Issue 6, Pages 721-731
Publisher
Springer Nature
Online
2012-09-02
DOI
10.1007/s11886-012-0309-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease
- (2012) Seung-Kwon Myung ARCHIVES OF INTERNAL MEDICINE
- Statins are diabetogenic – Myth or reality?
- (2012) Naveed Sattar et al. ATHEROSCLEROSIS SUPPLEMENTS
- Healthy Lifestyle Through Young Adulthood and the Presence of Low Cardiovascular Disease Risk Profile in Middle Age
- (2012) Kiang Liu et al. CIRCULATION
- Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy
- (2012) Samia Mora et al. CIRCULATION
- Executive Summary: Heart Disease and Stroke Statistics—2012 Update
- (2012) et al. CIRCULATION
- Ideal Cardiovascular Health in Childhood and Cardiometabolic Outcomes in Adulthood
- (2012) Tomi T. Laitinen et al. CIRCULATION
- Triglycerides
- (2012) Anthony S. Wierzbicki et al. CURRENT OPINION IN CARDIOLOGY
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Endothelial dysfunction in type 2 diabetes
- (2012) A. Natali et al. DIABETOLOGIA
- Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia
- (2012) H. Carlijne Hassing et al. HEPATOLOGY
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Meta-Analysis of Statin Effects in Women Versus Men
- (2012) William J. Kostis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The biology and therapeutic targeting of the proprotein convertases
- (2012) Nabil G. Seidah et al. NATURE REVIEWS DRUG DISCOVERY
- The emerging role of HDL in glucose metabolism
- (2012) Brian G. Drew et al. Nature Reviews Endocrinology
- Do Persons with Diabetes Benefit from Combination Statin and Fibrate Therapy?
- (2012) Paul D. Rosenblit Current Cardiology Reports
- Role of ω3 Longchain Polyunsaturated Fatty Acids in Reducing Cardio- Metabolic Risk Factors
- (2012) Mahinda Y. Abeywardena et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Hyperlipidemia
- (2011) Michel Farnier American Journal of Cardiovascular Drugs
- Gut-liver interaction in triglyceride-rich lipoprotein metabolism
- (2011) Changting Xiao et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects
- (2011) Marja-Riitta Taskinen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis
- (2011) Meng Lee et al. ATHEROSCLEROSIS
- Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A 1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
- (2011) Philip J. Barter et al. CIRCULATION
- Rosuvastatin, Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations, and LDL Cholesterol Response: the JUPITER Trial
- (2011) Z. Awan et al. CLINICAL CHEMISTRY
- Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
- (2011) F. Karpe et al. DIABETES
- Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials
- (2011) L. A. Leiter et al. DIABETES OBESITY & METABOLISM
- Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?
- (2011) D. Kromhout et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin
- (2011) David D. Waters et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipid control in patients with diabetes mellitus
- (2011) D. John Betteridge Nature Reviews Cardiology
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
- (2010) SHARP Collaborative Group AMERICAN HEART JOURNAL
- Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia
- (2010) Ann C Skulas-Ray et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion
- (2010) Michelle A. Fryirs et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
- (2010) Donald M. Lloyd-Jones et al. CIRCULATION
- A practical approach to the metabolic syndrome: review of current concepts and management
- (2010) Rajesh Tota-Maharaj et al. CURRENT OPINION IN CARDIOLOGY
- Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes
- (2010) M.-R. Taskinen et al. DIABETOLOGIA
- Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies
- (2010) Dick C Chan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis
- (2010) Eric Bruckert et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease
- (2010) Elisa Fabbrini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Combination Lipid Therapy in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
- (2010) M. John Chapman et al. PHARMACOLOGY & THERAPEUTICS
- HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk
- (2009) M.T. Cooney et al. ATHEROSCLEROSIS
- Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
- (2009) Paul M Ridker et al.
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Wirksamkeit und Sicherheit von Etofibrat bei Patienten mit nicht proliferativer diabetischer Retinopathie
- (2009) K.-H. Emmerich et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
- (2009) Paul M Ridker et al. LANCET
- Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives
- (2008) William S. Harris et al. ATHEROSCLEROSIS
- Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes: Results and projections from the Steno-2 study
- (2008) P. Gaede et al. DIABETES CARE
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes
- (2008) Jerome L. Fleg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now